Cecchi R, Paoli S, Giomi A, Rossetti R. Favus due to Trichophyton schoenleinii in a patient with metastatic bronchial carcinoma. Br J Dermatol. 2003 May. 148(5):1057. [QxMD MEDLINE Link].
Khaled A, Ben Mbarek L, Kharfi M, et al. Tinea capitis favosa due to Trichophyton schoenleinii. Acta Dermatovenerol Alp Panonica Adriat. 2007. 16:34-46.
Raszeja-Kotelba B, Adamski Z, Pawlowicz A. A case of tinea favosa capitis caused by Trichophyton schoenleinii. Przegl Dermatol. 1993. 80:518-24.
Besbes M, Cheikhrouhou F, Sellami H, Makni F, Bouassida S, Ayadi A. Favus due to Trichophyton mentagrophytes var. quinckeanum. Mycoses. 2003 Sep. 46(8):358-60. [QxMD MEDLINE Link].
Garcia-Sanchez MS, Pereiro M Jr, Pereiro MM, Toribio J. Favus due to Trichophyton mentagrophytes var. quinckeanum. Dermatology. 1997. 194(2):177-9. [QxMD MEDLINE Link].
Sun PL, Mu CA, Fan CC, Fan YC, Hu JM, Ju YM. Cat favus caused by Microsporum incurvatum comb. nov.: the clinical and histopathological features and molecular phylogeny. Med Mycol. 2014 Apr 1. 52(3):276-84. [QxMD MEDLINE Link].
Uhrlaβ S, Mey S, Storch S, Wittig F, Koch D, Krü Ger C, et al. Nannizzia incurvata as a rare cause of favus and tinea corporis in Cambodia and Vietnam. Indian J Dermatol Venereol Leprol. 2020 Jun 8. [QxMD MEDLINE Link].
Grappel SF, Blank F, Bishop CT. Circulating antibodies in human favus. Dermatologica. 1971. 143(5):271-6. [QxMD MEDLINE Link].
Farooqi M, Tabassum S, Rizvi DA, Rahman A, Rehanuddin, Awan S, et al. Clinical types of tinea capitis and species identification in children: an experience from tertiary care centres of Karachi, Pakistan. J Pak Med Assoc. 2014 Mar. 64(3):304-8. [QxMD MEDLINE Link].
Liu ZH, Xia XJ, Zhang Y, Zhong Y, Sang B, Li QP, et al. Favus of Scrotum Due to Trichophyton rubrum in Immunocompetent Patients: A Clinical, Mycological and Ultrastructural Study. Mycopathologia. 2019 Apr 11. [QxMD MEDLINE Link].
Ge LY, Liu J, Zheng HL, Mei H, Liang GZ, Liu WD. Comprehensive genome and transcriptome analysis of the dermatophyte Trichophyton schoenleinii reveals the candidate pathogenic genes. Mycoses. 2021 Feb 15. [QxMD MEDLINE Link].
Loveman AB, Kotcher E. Favus in Kentucky: diagnosis, treatment and epidemiology. J Ky Med Assoc. 1962 Jul. 60:643-55. [QxMD MEDLINE Link].
Pawlowicz A. Epidemiology of tinea capitis, particularly tinea favosa in the Poznan region. Postepy Dermatol (Poznan). 1996. 13:347-400.
Scott DB, Scott FP. Dermatophytoses in South Africa. Sabouraudia. 1973 Nov. 11(3):279-82. [QxMD MEDLINE Link].
Khan KA, Anwar AA. Study of 73 cases of tinea capitis and tinea favosa in adults and adolescents. J Invest Dermatol. 1968 Dec. 51(6):474-7. [QxMD MEDLINE Link].
Matte SM, Lopes JO, Melo IS, Beber AA. A focus of favus due to Trichophyton schoenleinii in Rio Grande do Sul, Brasil. Rev Inst Med Trop Sao Paulo. 1997 Jan-Feb. 39(1):1-3. [QxMD MEDLINE Link].
Prochnau A, de Almeida HL Jr, Souza PR, Vetoratto G, Duquia RP, Defferrari R. Scutular tinea of the scrotum: report of two cases. Mycoses. 2005 May. 48(3):162-4. [QxMD MEDLINE Link].
BLANK F. Human favus in Quebec. Dermatologica. 1962. 125:369-81. [QxMD MEDLINE Link].
Joly J, Delage G, Auger P, Ricard P. Favus: twenty indigenous cases in the province of Quebec. Arch Dermatol. 1978 Nov. 114(11):1647-8. [QxMD MEDLINE Link].
Zhan P, Geng C, Li Z, Jin Y, Jiang Q, Tao L, et al. Evolution of tinea capitis in the Nanchang area, Southern China: a 50-year survey (1965-2014). Mycoses. 2015 May. 58 (5):261-6. [QxMD MEDLINE Link].
Ilkit M. Favus of the scalp: an overview and update. Mycopathologia. 2010 Sep. 170(3):143-54. [QxMD MEDLINE Link].
García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermato. 2007. 57, suppl. 2:S19-S21.
Sanusi T, Gong J, Wang X, Zhao M, Zhao Y, An X, et al. Disseminated Favus Caused by Microsporum gypseum in a Patient with Systemic Lupus Erythematosus. Acta Derm Venereol. 2015 Aug 10. [QxMD MEDLINE Link].
Sanusi T, Gong J, Wang X, Zhao M, Zhao Y, An X, et al. Disseminated Favus Caused by Microsporum gypseum in a Patient with Systemic Lupus Erythematosus. Acta Derm Venereol. 2016 Mar 1. 96 (2):270-271. [QxMD MEDLINE Link].
Do N, Notaro E, Schillhammer G, Colven R. Tinea capitis mimicking favus in rural Washington State. JAAD Case Rep. 2020 Mar. 6 (3):187-188. [QxMD MEDLINE Link].
Iwasa K, Ogawa K, Azukizawa H, Tanabe H, Iwanaga T, Anzawa K, et al. Revival of favus in Japan caused by Trichophyton schoenleinii. J Dermatol. 2019 Apr. 46 (4):347-350. [QxMD MEDLINE Link].
Hu WH, Chan GK, Lou JS, Wu QY, Wang HY, Duan R, et al. The extract of Polygoni Cuspidati Rhizoma et Radix suppresses the vascular endothelial growth factor-induced angiogenesis. Phytomedicine. 2018 Mar 15. 42:135-143. [QxMD MEDLINE Link].
Kwasniewska J. Current antifungal agents in dermatology. Postepy Dermatol (Poznan). 1997. 14:129-35.
Lahmadi K, Elhaouri M. [Favique ringworm treated with terbinafine in a child of 11 years]. Pan Afr Med J. 2015. 22:368. [QxMD MEDLINE Link].
Deng S, Ansari S, Ilkit M, Rafati H, Hedayati MT, Taghizadeh-Armaki M, et al. In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China. Antimicrob Agents Chemother. 2017 Feb. 61 (2):[QxMD MEDLINE Link].
Ceburkovas O, Schwartz RA, Janniger CK. Tinea capitis: current concepts. J Dermatol. 2000 Mar. 27(3):144-8. [QxMD MEDLINE Link].